FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904121860> ?p ?o ?g. }

• W2904121860 endingPage "65" @default.
• W2904121860 startingPage "57" @default.
• W2904121860 abstract "To investigate the effects of chronic beta-alanine (BA) supplementation on muscle taurine content, blood clinical markers and sensory side-effects. Twenty-five healthy male participants (age 27 ± 4 years, height 1.75 ± 0.09 m, body mass 78.9 ± 11.7 kg) were supplemented with 6.4 g day−1 of sustained-release BA (N = 16; CarnoSyn™, NAI, USA) or placebo (PL; N = 9; maltodextrin) for 24 weeks. Resting muscle biopsies of the m. vastus lateralis were taken at 0, 12 and 24 weeks and analysed for taurine content (BA, N = 12; PL, N = 6) using high-performance liquid chromatography. Resting venous blood samples were taken every 4 weeks and analysed for markers of renal, hepatic and muscle function (BA, N = 15; PL, N = 8; aspartate transaminase; alanine aminotransferase; alkaline phosphatase; lactate dehydrogenase; albumin; globulin; creatinine; estimated glomerular filtration rate and creatine kinase). There was a significant main effect of group (p = 0.04) on muscle taurine, with overall lower values in PL, although there was no main effect of time or interaction effect (both p > 0.05) and no differences between specific timepoints (week 0, BA: 33.67 ± 8.18 mmol kg−1 dm, PL: 27.75 ± 4.86 mmol kg−1 dm; week 12, BA: 35.93 ± 8.79 mmol kg−1 dm, PL: 27.67 ± 4.75 mmol kg−1 dm; week 24, BA: 35.42 ± 6.16 mmol kg−1 dm, PL: 31.99 ± 5.60 mmol kg−1 dm). There was no effect of treatment, time or any interaction effects on any blood marker (all p > 0.05) and no self-reported side-effects in these participants throughout the study. The current study showed that 24 weeks of BA supplementation at 6.4 g day−1 did not significantly affect muscle taurine content, clinical markers of renal, hepatic and muscle function, nor did it result in chronic sensory side-effects, in healthy individuals. Since athletes are likely to engage in chronic supplementation, these data provide important evidence to suggest that supplementation with BA at these doses for up to 24 weeks is safe for healthy individuals." @default.
• W2904121860 created "2018-12-22" @default.
• W2904121860 creator A5002762974 @default.
• W2904121860 creator A5005567201 @default.
• W2904121860 creator A5014503392 @default.
• W2904121860 creator A5015359899 @default.
• W2904121860 creator A5042325405 @default.
• W2904121860 creator A5043754594 @default.
• W2904121860 creator A5051323334 @default.
• W2904121860 creator A5055521928 @default.
• W2904121860 creator A5070055460 @default.
• W2904121860 creator A5071293169 @default.
• W2904121860 creator A5074522308 @default.
• W2904121860 creator A5084228193 @default.
• W2904121860 date "2018-12-14" @default.
• W2904121860 modified "2023-10-14" @default.
• W2904121860 title "24-Week β-alanine ingestion does not affect muscle taurine or clinical blood parameters in healthy males" @default.
• W2904121860 cites W1886499497 @default.
• W2904121860 cites W1964665990 @default.
• W2904121860 cites W1977510100 @default.
• W2904121860 cites W2020637493 @default.
• W2904121860 cites W2026200262 @default.
• W2904121860 cites W2039663477 @default.
• W2904121860 cites W2041824571 @default.
• W2904121860 cites W2046971132 @default.
• W2904121860 cites W2054209064 @default.
• W2904121860 cites W2065665566 @default.
• W2904121860 cites W2067719177 @default.
• W2904121860 cites W2070129144 @default.
• W2904121860 cites W2086051350 @default.
• W2904121860 cites W2089502287 @default.
• W2904121860 cites W2093564136 @default.
• W2904121860 cites W2095264973 @default.
• W2904121860 cites W2097350777 @default.
• W2904121860 cites W2127234770 @default.
• W2904121860 cites W2127238287 @default.
• W2904121860 cites W2145539290 @default.
• W2904121860 cites W2157704372 @default.
• W2904121860 cites W2159899179 @default.
• W2904121860 cites W2321703570 @default.
• W2904121860 cites W2469243153 @default.
• W2904121860 cites W2537658336 @default.
• W2904121860 cites W2559869198 @default.
• W2904121860 cites W2576370101 @default.
• W2904121860 cites W2754260260 @default.
• W2904121860 cites W2762426016 @default.
• W2904121860 cites W2791581924 @default.
• W2904121860 cites W2866768542 @default.
• W2904121860 cites W4255692377 @default.
• W2904121860 doi "https://doi.org/10.1007/s00394-018-1881-0" @default.
• W2904121860 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30552505" @default.
• W2904121860 hasPublicationYear "2018" @default.
• W2904121860 type Work @default.
• W2904121860 sameAs 2904121860 @default.
• W2904121860 citedByCount "12" @default.
• W2904121860 countsByYear W29041218602019 @default.
• W2904121860 countsByYear W29041218602020 @default.
• W2904121860 countsByYear W29041218602021 @default.
• W2904121860 countsByYear W29041218602022 @default.
• W2904121860 countsByYear W29041218602023 @default.
• W2904121860 crossrefType "journal-article" @default.
• W2904121860 hasAuthorship W2904121860A5002762974 @default.
• W2904121860 hasAuthorship W2904121860A5005567201 @default.
• W2904121860 hasAuthorship W2904121860A5014503392 @default.
• W2904121860 hasAuthorship W2904121860A5015359899 @default.
• W2904121860 hasAuthorship W2904121860A5042325405 @default.
• W2904121860 hasAuthorship W2904121860A5043754594 @default.
• W2904121860 hasAuthorship W2904121860A5051323334 @default.
• W2904121860 hasAuthorship W2904121860A5055521928 @default.
• W2904121860 hasAuthorship W2904121860A5070055460 @default.
• W2904121860 hasAuthorship W2904121860A5071293169 @default.
• W2904121860 hasAuthorship W2904121860A5074522308 @default.
• W2904121860 hasAuthorship W2904121860A5084228193 @default.
• W2904121860 hasBestOaLocation W29041218602 @default.
• W2904121860 hasConcept C126322002 @default.
• W2904121860 hasConcept C134018914 @default.
• W2904121860 hasConcept C15744967 @default.
• W2904121860 hasConcept C185592680 @default.
• W2904121860 hasConcept C193230392 @default.
• W2904121860 hasConcept C2776035688 @default.
• W2904121860 hasConcept C2779701627 @default.
• W2904121860 hasConcept C2779856020 @default.
• W2904121860 hasConcept C42407357 @default.
• W2904121860 hasConcept C46312422 @default.
• W2904121860 hasConcept C515207424 @default.
• W2904121860 hasConcept C55493867 @default.
• W2904121860 hasConcept C71924100 @default.
• W2904121860 hasConceptScore W2904121860C126322002 @default.
• W2904121860 hasConceptScore W2904121860C134018914 @default.
• W2904121860 hasConceptScore W2904121860C15744967 @default.
• W2904121860 hasConceptScore W2904121860C185592680 @default.
• W2904121860 hasConceptScore W2904121860C193230392 @default.
• W2904121860 hasConceptScore W2904121860C2776035688 @default.
• W2904121860 hasConceptScore W2904121860C2779701627 @default.
• W2904121860 hasConceptScore W2904121860C2779856020 @default.
• W2904121860 hasConceptScore W2904121860C42407357 @default.
• W2904121860 hasConceptScore W2904121860C46312422 @default.
• W2904121860 hasConceptScore W2904121860C515207424 @default.

• next